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Abstract
Dysferlin was previously identified as a key player in muscle membrane repair and its deficiency leads to the development of
muscular dystrophy and cardiomyopathy. However, little is known about the oligomerization of this protein in the plasma
membrane. Here we report for the first time that dysferlin forms a dimer in vitro and in living adult skeletal muscle fibers
isolated from mice. Endogenous dysferlin from rabbit skeletal muscle exists primarily as a ,460 kDa species in detergent-
solubilized muscle homogenate, as shown by sucrose gradient fractionation, gel filtration and cross-linking assays.
Fluorescent protein (YFP) labeled human dysferlin forms a dimer in vitro, as demonstrated by fluorescence correlation
spectroscopy (FCS) and photon counting histogram (PCH) analyses. Dysferlin also dimerizes in living cells, as probed by
fluorescence resonance energy transfer (FRET). Domain mapping FRET experiments showed that dysferlin dimerization is
mediated by its transmembrane domain and by multiple C2 domains. However, C2A did not significantly contribute to
dimerization; notably, this is the only C2 domain in dysferlin known to engage in a Ca-dependent interaction with cell
membranes. Taken together, the data suggest that Ca-insensitive C2 domains mediate high affinity self-association of
dysferlin in a parallel homodimer, leaving the Ca-sensitive C2A domain free to interact with membranes.
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Introduction
The functionality of muscle cells is dependent upon the integrity
of the plasma membrane (sarcolemma). A membrane repair
mechanism involving multiple proteins such as dysferlin [1,2,3],
calpain [4], annexins A1/A2/A5 [3,5,6] and MG53 [7,8] has
been identified to restore the sarcolemmal integrity upon
membrane damage. Defects in the membrane repair machinery
are detrimental to normal muscle function and health. For
example, genetic defects in the DYSF gene lead to the development
of multiple muscular dystrophies. Such dysferlinopathies include
limb-girdle muscular dystrophy type2B (LGMD2B) [9,10],
Miyoshi myopathy [10] and a distal anterior compartment
myopathy [11]. In addition, dysferlin deficiency also causes the
development of cardiomyopathy [2,12,13,14].
Dysferlin is expressed in tissues including skeletal muscle, heart,
kidney, placenta, lung, and brain [9]. Despite the progress in
establishing the function of dysferlin in muscle membrane repair
[1,2,3,15], little is known about how dysferlin exerts its function.
Dysferlin is a 230 kDa type II transmembrane protein, belonging
to the ferlin-1-like protein family [9,16]. All ferlin-1-like proteins
contain multiple C2 domains that were known to possess the
characteristics of Ca
2+-dependent phospholipid binding activities
[17,18]. Indeed, the first C2 domain (designated as C2A) of
dysferlin was observed to bind to phospholipids in a Ca
2+
dependent fashion [17,18]. Mutations within the C2A domain of
dysferlin reduced the Ca
2+-facilitated phospholipid binding
activity [17,18]. However, the other C2 domains in dysferlin
exhibited weaker Ca
2+-independent or no binding to phospholip-
ids [18]. This raises an interesting yet unresolved question: what is
the role of the other six C2 domains? Previous studies
demonstrated that C2 domains, in addition to mediating Ca
2+-
sensitive membrane binding activity, could also mediate protein-
protein interactions [19,20,21]. In particular, the C2 domains
dimerization has been reported for RIM1a [22] and Munc13 [23].
To test whether the C2 domains in dysferlin mediate dysferlin
oligomerization, we employed a combination of biochemical and
optical approaches to study the self-interaction of dysferlin in vitro
and in living cells.
Results
Endogenous dysferlin is present as a high molecular
mass species in vitro
We used ion exchange chromatography to enrich dysferlin from
rabbit skeletal muscle microsomes. When digitonin (1%)-solubi-
lized KCl-washed microsomes of rabbit skeletal muscle was
applied to DEAE cellulose and step-eluted with increasing NaCl
concentrations, the 150 mM NaCl wash fraction was enriched
with dysferlin. We then ran the dysferlin-enriched fraction from
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probed the fractions with a dysferlin antibody (Hamlet-1). As
shown in Fig. 1A, dysferlin migrated into heavier fractions 8–13,
suggesting that dysferlin exists as high-molecular-weight species
(through self-association or binding to some other proteins).
To obtain further information about the sizes of dysferlin
complexes, we analyzed purified dysferlin (in 1% CHAPS) by size
exclusion FPLC over Superose 6 columns. The elution profile was
shown in Fig. 1B. Purified dysferlin was detected with the peak in
the fractions near ferritin (440 kDa), twice of the apparent MW of
monomeric dysferlin (230 kDa). This result indicates that dysferlin
forms a dimer in solution.
To further investigate the high MW species, we incubated
rabbit skeletal muscle microscomes with 100 mM bifunctional
maleimide cross-linker N,N9-o-phenylenedimaleimide (o-PDM;
rigid 6 A ˚), and then analyzed the samples by SDS-PAGE. In o-
PDM treated samples dysferlin existed as two discrete bands, one
at 230 kDa and the other at 460 kDa (Fig. 1C). These data
consistently support that dysferlin in vitro forms a homodimeric
complex.
Dysferlin forms a dimer in living HEK293 cells
To test whether dysferlin forms self-associated complex in living
cells, we performed the FRET assay on transiently transfected
HEK293 cells (Stratagene). We have previously used this assay to
investigate the interactions of muscle proteins including SERCA
and phospholamban (PLB) [24,25,26]. HEK293 cells do not
express dysferlin endogenously, allowing us to study the dysferlin
self-interaction without interference from the endogenous dysfer-
lin. Confocal microscopy and total internal reflection fluorescence
(TIRF) microscopy showed that CFP/YFP-dysferlin was localized
at the cell membrane and in intracellular vesicles in HEK293 cells
(Fig. 2A).
Energy transfer between CFP-dysferlin and YFP-dysferlin was
detected by acceptor-selective photobleaching. Selective photo-
bleaching of YFP resulted in a concomitant increase in CFP-
dysferlin fluorescence (Fig. 2B,C), indicating FRET from CFP-
dysferlin to YFP-dysferlin. To probe the stoichiometry of the
oligomeric complex that gives rise to FRET, the relationship of
CFP and YFP fluorescence emission was examined as described
previously [24,27]. A highly linear relationship was observed
between CFP-dysferlin and YFP-dysferlin emissions during the
progressive YFP photobleaching (Fig. 2D), consistent with a
homodimeric complex. This is in contrast to the highly nonlinear
donor-acceptor relationships previously observed for PLB [24] and
phospholemman [25] homooligomers with the subunit number
.2 [27]. The linear regression y-intercept (Fig. 2D) also provides
a measure of the FRETmax between CFP-dysferlin and YFP-
dysferlin (26.860.1%, N=187). This FRET value is significantly
higher than the nonspecific FRET for membrane proteins that was
characterized previously in the same setup (,4%) [28], affirming
the specificity of dysferlin self-interaction.
Dysferlin vesicles were highly mobile in HEK293 cells. These
vesicles, when moving into or out of the focus, may interfere with
the fluorescence measurement during progressive YFP photo-
bleaching which usually takes around 6 minutes, thus affecting the
FRET measurement. As a complementary approach, we also
measured FRET using the ‘‘three-cube’’ fluorescence microscopy
[29,30,31] as this method is fast and nondestructive. Since the
movement of the cells and the vesicles during fast three-cube
imaging is negligible, FRET calculation can be performed in a
pixel-by-pixel fashion after background subtraction. The calculat-
ed FRET efficiency averaged from 3210 pixels was 20.662.1%,
consistent with the acceptor-selective photobleaching method.
The C2 domains and the transmembrane domain
mediate dysferlin dimerization
Dysferlin contains multiple C2 domains, which are potentially
involved in mediating dysferlin dimerization. To test this, we
generated the CFP and YFP fusion constructs containing each
individual C2 domain, and examined their self-interactions in
HEK293 cells using FRET assays. Interestingly, the C2A domain
did not bind to itself while all the other C2 domains showed
significant self-interactions (Fig. 3A&B). To obtain the relative
binding energetics, we surveyed large populations of cells
expressing fluorescently tagged proteins and compared each cell’s
FRET efficiency with its YFP fluorescence intensity, which is an
index of protein expression [24,25,28,32,33]. For C2B to C2G,
FRET efficiency increased with increasing protein expression - a
relationship that can be approximated by a hyperbolic fit in the
form y=(FRETmax)x/(KD+x). The parameter FRETmax is the
maximal FRET, taken to represent the intrinsic FRET of the
bound complex, and KD represents the protein concentration at
which half-maximal FRET is achieved [dissociation constant, in
arbitrary units (AU)]. These data are pooled and averaged in
Figure 1. Biochemical analyses of endogenous dysferlin from
skeletal muscle in vitro. (A) Dysferlin-enriched fraction from DEAE
column (150 mM NaCl) was run onto a 5–30% linear sucrose gradient.
Total 13 fractions were taken from the top to the bottom of the
gradient and analyzed by SDS-PAGE. Dysferlin (Dysf) was detected in
the heavy fractions overlapping the dystrophin-glycoprotein complex
detected by the a-dystroglycan (DG) antibody. (B) Gel filtration profile
of purified dysferlin. The elution volumes (ml) were shown below the
lanes. The first lane was the starting material - purified dysferlin. The
standards elution profiles (marked with the arrows: thyroglobulin,
669 kDa; ferritin, 440 kDa; catalase, 232 kDa; aldolase, 158 kDa,
albumin, 67 kDa) off the column were linear and had an R
2 value of
0.974. (C) Rabbit skeletal muscle microsomes were treated with or
without 100 M o-PDM and the samples were analyzed by SDS-PAGE
and western blotting analysis. Dysferlin was detected at 230 kDa and
460 kDa (using ryanodine receptor (RyR) as a molecular marker).
doi:10.1371/journal.pone.0027884.g001
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dependences. The mean FRETmax and KD values are summarized
in Fig. 3D and Fig. 3E, respectively. Beside the C2 domains, we
observed that the transmembrane domain of dysferlin is also
involved in the dimerization (Fig. 3B). We also tried to measure
the FRETmax and KD of full-length dysferlin using the same
method. However, we observed no significant changes in
measured FRET efficiency with a broad range of acceptor protein
concentrations (from 0.23 to 15 in A.U.) (Fig. 3C), indicating that
KD for dysferlin is very small, at least smaller than the lowest
concentration examined (0.23 A.U.).
Dysferlin forms self-associated complex in living adult
skeletal muscle fibers
To test whether dysferlin also forms dimers in living muscle
fibers, flexor digitorum brevis (FDB) muscles of dysferlin-deficient mice
were transfected with CFP-dysferlin and YFP-dysferlin by
electroporation [34,35], and individual FDB muscle fibers were
isolated by collagenase digestion [36]. The positively transfected
FDB muscle fibers (Fig. 4A) were similarly assayed by acceptor-
selective photobleaching method and three-cube fluorescence
microscopy. As in HEK293 cells, selective YFP photobleaching
resulted in a concomitant increase in CFP-dysferlin fluorescence in
FDB muscle fibers (Fig. 4B). The inverse relationship between
CFP-dysferlin and YFP-dysferlin fluorescence intensity during
YFP-dysferlin photobleaching was also highly linear (Fig. 4C),
indicating that dysferlin in adult skeletal muscle fibers also forms a
dimer. Fig. 4D showed no significant changes in measured FRET
efficiency over all achievable protein concentrations (from 0.23 to
30 in A.U.), again suggesting that the KD for dysferlin dimer is too
low to be measured. The FRETmax (33.360.1%, taken from the
linear regression y-intercept in Fig. 4C) measured from FDB
muscle fibers were higher than that in HEK293 cells, suggesting
that muscle cell environment favors a tighter dysferlin dimer
formation.
Finally, to ascertain that the fluorescent protein tag does not
impact the function of dysferlin, we examined the membrane
repair capacity of the muscle fibers with or without CFP-dysferlin.
When FM 1–43-labeled sarcolemma were irradiated with an 880-
nm infra-red laser beam at full power, the FM 1–43 fluorescence
intensities were increased at the irradiation site indicating of
membrane damage (Fig. 4E). In contrast to wild-type muscle
fibers, the dysferlin-deficient muscle fibers lost the ability to stop
the fluorescence increase (Fig. 4E) due to compromised
membrane repair as reported previously [1,2]. However, CFP-
dysferlin, when introduced into dysferlin-deficient muscle fibers,
fully restored the membrane repair capacity in these cells (Fig. 4E).
These data suggest that the fluorescent protein tag does not impair
the structure and/or function of dysferlin when fused in the N
terminus of dysferlin.
Fluorescence correlation spectroscopy and photon
counting histogram analyses
To further investigate dimerization of dysferlin in in vitro,w e
performed fluorescence correlation spectroscopy on enhanced
YFP-labeled dysferlin or free YFP diffusing in detergent solution.
As expected, there was a marked difference in the correlation time
of the small, freely diffusible YFP compared to YFP fused to
dysferlin in detergent micelles. This is evident as a significantly
right-shifted correlation of YFP-dysferlin compared to YFP
(Fig. 5A, black). Interestingly, we also observed differential
diffusion of YFP-dysferlin in various detergents (Fig. 5B). The
Figure 2. Dysferlin self-interaction in living HEK293 cells shown by acceptor-selective photobleaching FRET assay. (A) Confocal
microscopy and total internal reflection fluorescence (TIRF) microscopy images of YFP-dysferlin expressed in HEK293 cells. Scale bars: 10 mm. (B) CFP-
dysferlin and YFP-dysferlin fluorescence images before (Prebleach) and after (Postbleach) YFP-selective photobleaching. Scale bar: 5 mm. (C)
Quantitative analysis of CFP-dysferlin and YFP-dysferlin fluorescence intensities (F/F0) during YFP-selective photobleaching. (D) The relationship
between the normalized fluorescence of CFP-dysferlin and the normalized fluorescence of YFP-dysferlin during progressive photobleaching was
linear, consistent with a homodimeric dysferlin complex.
doi:10.1371/journal.pone.0027884.g002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27884Figure 3. Mapping the determinants of dysferlin dimerization. (A) Dependence of FRET efficiencies on the protein expression levels of C2A to
C2D domains of dysferlin. Hyperbolic fitting showed that the C2B (red), C2C (green) and C2D (purple) domains of dysferlin all mediate the self-
interaction. There was no FRET for C2A construct (black). (B) Dependence of FRET efficiencies on the protein expression levels of C2E to C2G domains
and the transmembrane (TM) domain of dysferlin. Hyperbolic fitting showed that the C2E (black), C2F (red), C2G (green) and TM (purple) domains of
dysferlin also mediate the self-interaction. In A and B, the data were pooled for easy comparison. (C) Independence of dysferlin dimer FRET
efficiencies on acceptor concentrations within the range examined. (D) Summary of FRETmax values obtained by fitting (expressed as mean 6 S.E.M.).
(E) Summary of KD values obtained by fitting (expressed as mean 6 S.E.M.). ND: not determined.
doi:10.1371/journal.pone.0027884.g003
Figure 4. FRET analyses of adult FDB muscle fibers transfected with CFP-dysferlin and YFP-dysferlin. (A) CFP-dysferlin and YFP-dysferlin
fluorescence images before (Prebleach) and after (Postbleach) YFP-selective photobleaching. Scale bar: 20 mm. (B) Linear relationship between CFP-
dysferlin and YFP-dysferlin fluorescence suggests dysferlin forms a dimer in FDB muscle fibers. (C) Independence of dysferlin dimer FRET efficiencies
on YFP-dysferlin concentrations within the range examined. (D) Membrane repair defect in dysferlin-deficient muscle fibers was corrected by the CFP-
dysferlin, suggesting that the fluorescent protein tag on dysferlin does not compromise the function of dysferlin.
doi:10.1371/journal.pone.0027884.g004
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detergents (1% CHAPS, Fig. 5B, red and 0.5% DDM, Fig. 5B,
blue) were well described by a single species diffusion model
(Equation 1), with a correlation time of 2.7 ms. This corresponds
to a diffusion coefficient (D) of 33 mm
2 s
21 (Table 1). However, in
a negatively-charged denaturing detergent SDS (Fig. 5B, green)
YFP-dysferlin correlation time was decreased to 2.1 ms
(D=42 mm
2 s
21), suggesting a smaller molecular weight species.
Using a model of diffusion of a spherical shape (Equation 3), FCS
measurements yielded estimates of hydrodynamic radii of 59 and
75 A ˚ for dysferlin in SDS and DDM/Chaps, corresponding to
apparent molecular weights of 315 and 649 kD, respectively. Note
that these apparent molecular weights are probably overestimates,
since dysferlin is not expected to have a spherical shape. The two-
fold difference in the apparent molecular weights is suggestive of a
DDM/Chaps-stable dimer that is dissociated by SDS. Triton X-
100 solubilization yielded a YFP-dysferlin correlation (Fig. 5B,
gray) that was intermediate between SDS and DDM/Chaps,
consistent with a mixture of monomers and dimers. Indeed, a 2-
species fit (Equation 2) revealed that 83% of the molecules
diffused with a correlation time of 2.1 ms, and 17% diffused with a
correlation time of 2.7 ms (Table 1). The data suggest that the
dysferlin complex is partially destabilized by Triton X-100, but
some dimers remain.
We also performed PCH analysis of detergent solubilized YFP-
dysferlin to determine the molecular brightness (e) of diffusing
Figure 5. Fluorescence correlation spectroscopy and photon counting histogram analyses of dysferlin dimerization. (A) FCS data
obtained from YFP control (black) showed a significantly faster diffusion compared to full length YFP dysferlin in detergent solution. The boxed
region is enlarged and reproduced in the next panel. (B) Diffusion of YFP-dysferlin in 1% CHAPS (red) and 0.5% DDM (blue) were well described by a
single species diffusion model (Equation 1), with a correlation time of 2.7 ms. This the apparent diffusion time constant was decreased in SDS
(green) to 2.1 ms, suggesting a smaller species half the size of YFP-dysferlin in CHAPS or DDM. Triton X-100 solubilization yielded a YFP-dysferlin
correlation (gray) that was intermediate between SDS and DDM/CHAPS. These data were best described by a fit to 2 species differing in molecular
weight by 2-fold (Equation 3). The data suggest that the dysferlin complex is partially destabilized by Triton X-100, but some dimers remain. (C) PCH
analysis yielded the molecular brightness (e) of diffusing species, normalized to the brightness of control monomeric YFP. The molecular brightness
of monomers and dimers are highlighted (dotted red lines). YFP-dysferlin in CHAPS and DDM had a molecular brightness exactly twice the measured
brightness of monomeric YFP, suggesting stable dimers in these detergents. YFP-dysferlin in Triton X-100 and individual C2-domains all yielded
intermediate molecular brightness, which is compatible with a mixture of monomers and dimers. *** indicates p,0.001, ** p,0.01 and * p,0.05
when compared to the molecular brightness of YFP.
doi:10.1371/journal.pone.0027884.g005
Table 1. Summary of FCS experiments.
Sample tD (ms) D (mm
2 s
21)r h (A ˚)
EYFP 0.9360.05 0.95 26.161.9
Dysferlin in SDS 2.1260.11 0.4260.03 59.264.2
Dysferlin in CHAPS 2.6960.13 0.3360.02 75.365.3
Dysferlin in DDM 2.7260.14 0.3360.02 75.965.4
Dysferlin in Triton 2.1260.11
2.7260.14
0.4260.03
0.3360.02
59.464.2
76.165.4
Parameters shown are observed diffusion correlation time (tD), diffusion
coefficient (D), and apparent hydrodynamic radius (rh).
doi:10.1371/journal.pone.0027884.t001
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which one component was background autofluorescence. For YFP
and YFP-dysferlin in SDS, the remaining component gave a
molecular brightness of 4900 cpsm, which compares well with
previous measurements of monomeric fluorescent proteins using
low excitation power [38,39]. YFP-dysferlin in CHAPS and DDM
had a molecular brightness exactly twice the measured brightness
of monomeric YFP (Fig. 5C), suggesting stable dimers in these
detergents. The photon counting statistics were not sufficient for a
3-species fit of data obtained from YFP-dysferlin in Triton X-100,
but this detergent yielded an apparent intermediate molecular
brightness (Fig. 5C), which is compatible with a mixture of
monomers and dimers. Similar results were obtained for individual
C2 domains. Fig. 5C shows the results of PCH analysis of C2C-
C2G, which yielded intermediate molecular brightness values
consistent with mixtures of monomer and dimer species. These
data are consistent with FRET experiments that showed that
individual C2 domains were capable of dimerization, but with
reduced affinity compared to full-length dysferlin (Fig. 4).
Discussion
In the present work, we examined the stoichiometry of dysferlin
using biophysical and biochemical approaches, and demonstrated
for the first time that dysferlin forms a homodimer through the
transmembrane domain and C2 domains.
Both sucrose gradient fractionation and gel filtration experi-
ments showed that dysferlin existed as high MW species. SDS-
PAGE analysis of cross-linked dysferlin revealed an apparent MW
of 460 kDa, twice that of monomeric dysferlin, suggesting that
dysferlin dimerizes in vitro. Dysferlin dimerization in vitro is further
supported by PCH experiments that showed YFP-dysferlin in mild
detergent (DDM) had a two-fold higher molecular brightness vs.
YFP alone. PCH and FCS experiments also showed that the
dimers were partially dissociated by triton X-100, and fully
dissociated by SDS, which is compatible with a model of specific
avid self-interactions of YFP-dysferlin.
Dysferlin dimerization is also suggested by FRET experiments
in live cells. Using acceptor-photobleaching FRET and E-FRET,
we consistently observed significant energy transfer between
ECFP-dysferlin and EYFP-dysferlin in both HEK293 cells and
muscle fibers. The FRET efficiency depends on the donor-to-
acceptor separation distance R according to the relationship
described by Fo ¨rster R=(R0)[(1/FRETmax)21)]
1/6 [40], where R0
is the Fo ¨rster radius (49.2 A ˚ for the CFP-YFP pair [41]). The
FRETmax values (26.860.1% and 33.360.1% in HEK293 cells
and muscle fibers, respectively) obtained for dysferlin after the
subtraction of 4% nonspecific FRET as previously described
[24,28] correspond to CFP-YFP probe separation distance (R) of
58.2 and 57.0 A ˚ in HEK293 cells and muscle fibers, respectively.
It is noteworthy that the probe separation distance measured in
HEK293 cells was longer than that obtained from muscle fibers.
Possibly dysferlin favors a more compact dimeric structure in
skeletal muscle compared to heterologous cells.
The observed self-interactions mediated by many C2 domains
and the transmembrane domain of dysferlin suggest that multiple
regions of the dysferlin structure contribute to binding. The
binding energies for individual domains are expected to be
additive for the full-length protein, with exponential consequences
for the dissociation constant, according to the relationship
DG=2RT*ln(KD). For example, a doubling of binding energy
would reduce the KD by more than 7-fold. Thus, the avid self-
interaction of discrete C2 domain fragments accounts for the
observation that an ensemble of many C2 domains in full length
dysferlin yielded a KD that was too low to measure. The high
binding affinity makes it likely that dysferlin subunits come
together en route to the plasma membrane, and that dysferlin exists
as an obligate dimer in vivo.
The present observations are summarized in a schematic
diagram in Fig. 6A. In dysferlin, only the first C2 domain was
reported to possess the Ca
2+-facilitated phospholipid binding
activity [17,18] that is characteristic of C2 domains [42]. The
present study showed that the rest of the C2 domains bind with
differential affinity to their homologous partners to mediate
dysferlin self-interactions. Based upon these observations, we
believe that dysferlin dimer takes a parallel configuration (Fig. 6A).
This arrangement is also consistent with FRET experiments, since
an anti-parallel arrangement of full-length dysferlin would
probably not give rise to FRET (though it would still be detected
as a dimer by FCS, PCH, and other methods). The domains in
Fig. 6A are color-coded to indicate their relative binding affinities.
C2F contributes the most to binding, followed by the C2B, C2G,
transmembrane domain, and then C2D, C2C and C2E. Since the
C-terminus of dysferlin is anchored into a membrane, this parallel
dimeric structure leaves the other end of dysferlin dimer with two
C2A domains that do not bind to each other, but are free to
interact with membranes (Fig. 6A). We propose that after
membrane disruption, the high concentrations of Ca
2+ flood into
the cell, triggering membrane binding of the C2A domains. We
envision several possible non-exclusive mechanisms of membrane
repair mediated by dysferlin dimer localized at the sarcolemma
and the vesicles (Fig. 6B–E). Ca
2+ may trigger dysferlin anchored
in intracellular vesicles to bind to the broken sarcolemma (Fig. 6B)
or to other nearby vesicles (Fig. 6C). Dysferlin anchored in the
sarcolemma could bind via C2A domains to intracellular vesicles
(Fig. 6D) or to adjacent broken sarcolemma (Fig. 6E). In all
cases, the vesicles (or membranes) are pulled together at the site of
damage, accumulating a membrane barrier around the damage
site and separating the high Ca
2+ zone from the bulk cytoplasm.
The previous observation that dysferlin-containing membrane
patches are accumulated at the damaged muscle fibers [1] is
consistent with this model.
Taken together, our data suggest that dysferlin possesses two
types of C2 domains. C2A domains do not interact with another,
but they mediate Ca
2+-dependent phospholipid binding; C2B-F
domains mediate protein-protein interactions, and together with
the transmembrane domain they support dimerization of dysferlin.
Understanding the dimeric nature of dysferlin is an essential step
in revealing the mechanisms of dysferlin-mediated membrane
repair and developing therapeutic drugs that could be useful in the
treatment of dysferlinopathies.
Materials and Methods
Ethics Statement
All animal studies were reviewed and approved by the
Institutional Animal Care and Use Committee of Loyola
University Chicago (LU#202288 and LU#202769). Mice were
maintained at Loyola University Medical Center Animal Facility
in accordance with animal usage guidelines.
Biochemical analysis of skeletal muscle
KCl-washed membrane preparations were prepared from
rabbit skeletal muscles as previously described [43], and
solubilized with 1% digitonin. Digitonin (1%)-solubilized mem-
brane proteins were diluted 10 fold, applied to a 1-ml DEAE-
cellulose column (DE-52, Whatman) and sequentially eluted with
increased NaCl concentrations (mM): 50, 100, 150, 200, 300, 400,
Dysferlin Forms a Homodimer
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27884500 and 750. The elution fractions were examined by SDS-PAGE
and western blotting analysis. Dysferlin-enriched fraction was
loaded onto 10–30% sucrose gradients (Biocomp Instruments) and
sedimented at 220,0006 g for 2 h. 13 fractions were collected
from the top (light) to the bottom (heavy) of the gradients, and
examined by SDS-PAGE and western blotting analysis.
Superose 6 FPLC
FPLC analyses were performed with an Amersham Biosciences
AB Superose 6 HR 10/30 column. The standards elution profile
off the column were linear and had an R
2 value of 0.974. His6-
tagged dysferlin was purified using His-tag Dynabeads (Invitrogen)
from the HEK 293 cells transfected with Fugene 6 (Roche). The
mobile phase was 1% CHAPS, 150 mm NaCl, 50 mm Tris
(pH 7.5) and run at 0.4 ml/min. The column eluates were
fractionated into 100-ml aliquots and resolved by 4–15% SDS-
PAGE followed by Western blotting with a monoclonal anti-
dysferlin antibody Hamlet (Novacastra).
Crosslinking assays
Rabbit skeletal muscle microsomes were treated with or without
100 mM o-PDM (Sigma-Aldrich) on ice for 30 min, or 5 mM
diamide for 10 min at room temperature. The reactions were
stopped after by addition of 5 mM N-ethylmaleimide, followed by
addition of Laemmli sample buffer. The samples were analyzed by
SDS-PAGE and western blotting.
Western blotting
Protein samples were separated by SDS-PAGE and transferred
onto PVDF membranes. The mouse monoclonal antibodies anti-
dysferlin (Hamlet, Novacastra), anti-ryanodine receptor (XA7 B6,
Developmental Studies Hybridoma Bank), and anti-GFP (clone
3F8.2, Millipore) were used for immunoblotting analysis. Alexa
Fluor 488 or 633-conjugated secondary antibodies were obtained
from Invitrogen. The membranes were imaged for fluorescence
using the Typhoon Trio plus imager (GE Healthcare Life
Sciences, Inc.).
Plasmids
Full-length human dysferlin cDNA, obtained from a clone
DKFZp686K20163Q (RZPD, German) and a clone FLJ00175
(Kazusa DNA Research Institute, Japan), was subcloned into
pEGFP-C3 (CLONTECH Laboratories, Inc.). To make CFP-
dysferlin (CFP-dysferlin) and YFP-dysferlin (YFP-dysferlin) plas-
mids, the EGFP fragment in the EGFP-dysferlin construct was
replaced with CFP or YFP which were amplified from pYFP-N1
and pCFP-N1 (CLONTECH Laboratories, Inc.). Different C2
domain constructs were generated by PCR. The CFP- and YFP-
tagged constructs were used for the FRET studies, whereas YFP-
tagged constructs were used in the biochemical and FCS
experiments.
Cell Culture and Transfection
HEK293 cells (Stratagene, Catalog No. 240073) were cultured
in DMEM media supplemented with 10% FBS under 5% CO2 at
37uC. Transient transfection of HEK293 cells was performed by
using Fugene 6 reagent (Roche) as suggested by the manufacturer.
After 48 hours post-transfection, the cells were trypsinized and re-
plated onto poly-D-lysine (Sigma-Aldrich) coated 4-well glass
chambers (Lab-Tek, Nunc). For FRET experiment, 0.1 mg/well
each of the plasmids with CFP and 0.5 mg/well each of the
plasmids with YFP were co-transfected into HEK293 cells on 12-
well plate. For biochemical experiments, 6.0 mg each of the
plasmids with YFP was transfected into HEK 293 cells on 10-cm
culture dish. After 48 hours post-transfection with the plasmids,
cells were harvested in cold lysis buffer containing (mM): 50 Tris-
HCl, pH 7.5, 150 NaCl, 1 EDTA, 0.5% n-dodecyl beta-D-
maltoside (DDM), 0.2 phenylmethanesulfonylfluoride, and 1.0
benzamidine. Cell lysates were centrifuged at 14,000 rpm for
45 minutes and supernatants were collected. The protein samples
were separated and blotted as described above.
Electroporation and isolation of FDB muscle fibers
Electroporation-mediated gene transfer into flexor digitorum brevis
(FDB) muscle of mice was performed as described previously [35].
Figure 6. Schematic model of dysferlin protein. (A) We propose dysferlin forms a parallel homodimer through physical interactions of domains
C2B to C2G and the transmembrane domains. The domains are color-coded according to measured dissociation constants to indicate the relative
contribution of each domain to dimerization. After membrane damage, Ca
2+ enters the cell and binds to the C2A domains. Ca
2+-dependent C2A-
membrane interactions result in bridging of two membranes: vesicle to plasma membrane (B, D), vesicles to vesicles (C), and two sides of the broken
plasma membrane (E), thus promoting the formation of a dysferlin-membrane barrier surrounding membrane pores to accomplish membrane repair.
doi:10.1371/journal.pone.0027884.g006
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age were anesthetized with ketamine/xylazine (87.5 mg/kg and
12.5 mg/kg, respectively). The feet were subcutaneously injected
with 10 mL of the hyaluronidase solution (2 mg/ml) under the
footpads using Hamilton syringe. After one hour, 15 mg CFP-
dysferlin and 15 mg YFP-dysferlin plasmids (in 20 ml total volume)
or otherwise specified were injected subcutaeneously under the
footpads. The mice were allowed to fully recover in their cages
under observation. After five to seven days post-electroporation,
the mice were sacrificed and FDB muscles were dissected out. To
isolate individual FDB muscle fibers, the FDB muscles were placed
in Tyrode buffer containing 0.2% collagenase type 1A (Sigma-
Aldrich) at 37uC for 15 minutes. After extensive wash with fresh
Tyrode solution, the muscles were triturated with an open-mouth
pipette to release individual FDB muscle fibers. The isolated FDB
muscle fibers were plated onto 4-well glass chambers (Lab-Tek,
Nunc), pre-coated with 1 mg/ml laminin (BD Biosciences), and
imaged on fluorescence microscope or confocal microscope.
Confocal and TIRF Microscopy
Cells transfected with fluorescent protein fusion constructs were
imaged with a confocal microscope (TCS-SP5, Leica Microsys-
tems), using the 514 nm line of an argon continuous laser as the
excitation source. Fluorescence emission was collected with a
636water immersion objective (HCX PL APO, 1.2 NA). Total
internal reflection fluorescence (TIRF) imaging was also per-
formed with an inverted fluorescence microscope as described
[26]. To observe CFP fluorescence, a 449-nm diode laser was used
for excitation. To observe YFP emission, a 514-nm argon laser was
used for excitation. Fluorescence signals were collected through a
back-thinned electron-multiplying charged couple device camera
(Andor Technology) using the Metamorph software (Molecular
Devices).
Membrane repair assay
The membrane repair assay was performed essentially as
previously described [1,2,44]. Briefly, isolated FDB muscle fibers
were incubated in the Tyrode solution in 4-well glass-chamber
(Lab-Tek, Nunc). The FDB muscle fibers were first imaged for
CFP emission, and then 2.5 mM FM 1–43 (Invitrogen) was added
into the chamber for the membrane repair assay. The cells with or
without CFP-dysferlin fluorescence were selected. Membrane
damage was induced in the presence of with a 2-photon confocal
laser-scanning microscope (TCS-SP5, Leica Microsystems) cou-
pled to a 10-W Argon/Ti:sapphire laser. After initial images were
scanned, a 5-mm65-mm area of the sarcolemma of the muscle fiber
was injury with 1.5-s irradiation at full power. Fluorescence images
were captured at 10-second intervals for 5 min after the damage.
The fluorescence intensities at the damaged site were quantified by
using the ImageJ software (NIH) and plotted against the time after
the damage.
FRET detection and analysis
FRET was quantified by acceptor-selective photobleaching and
three-cube fluorescence microscopy.
Acceptor-selective photobleaching. Cells were imaged
using inverted Nikon TE2000-U microscope equipped with a
metal halide lamp, an APO 6061.49 NA objective, and a back-
thinned CCD camera (iXon 887; Andor Technology, Belfast,
Northern Ireland). The CCD camera was cooled to 2100uC, using
a recirculating liquid coolant system (Koolance, Inc., Auburn, WA).
CFP was excited at 427/10 nm and emission was collected with a
472/30 nm filter. YFP was excited at 504/12 nm and emission was
collected with a 542/27 nm filter. CFP images were acquired for
100 ms and YFP for 40 ms, followed by 10-s exposure of YFP-
selective photobleaching. Lamp output was set to 25% by a 0.6 ND
filter in the light path. The intensity of this YFP photobleaching
excitation was 230 micro-watts measured at the sample. At this
power level, YFP fluorescence is reduced by more than 95% in
10 min, but CFP fluorescence is preserved. This protocol has been
validated with standard samples [24] and used extensively
[24,25,28,32,33]. Image acquisition was automated with
Metamorph software. Fifty CFP-dysferlin and YFP-dysferlin
images were collected and the entire procedure lasted about
6 minutes. Images were analyzed with NIH ImageJ software. Cell
fluorescence intensities of CFP and YFP during photobleaching
were measured and background signal was subtracted from each
image. The pre- and post-bleach CFP fluorescence intensities were
used tocalculateFRET efficiency:FRET=12(Fprebleach/Fpostbleach)
[24,25,28,32,33]. To obtain the stoichiometry of the oligomeric
complex that gives rise to FRET [24,27], the CFP fluorescence
emission was plotted against YFP fluorescence emission during
photobleaching, and a linear regression was performed to examine
the linearity of those two sets of signals. The maximal energy
transfer efficiency (FRETmax) and the dissociation constants (KD)
were obtained from a hyperbolic fit with the equation
FRET(x)=(FRETmax)x/(KD + x), where x is the protein concen-
tration [24,25,28,32,33]. In cell-based FRET assays the units are
arbitrary because the protein concentration is determined from the
fluorescence intensity [24,25,28,32,33]. YFP fluorescence intensity
was used as an index of protein concentration.
Three-cube fluorescence microscopy. FRET was also
measured with a ‘‘three-cube’’ method (E-FRET) [28,31]. FRET
was calculated according to: E~
IDA{aI AA ðÞ {dI DD ðÞ
IDA{aI AA ðÞ z G{d ðÞ IDD ðÞ
where IDD is the intensity of fluorescence emission detected in the
donor channel (472/30 nm) with 427/10 nm excitation; IAA is the
intensity of fluorescence emission detected in the acceptor channel
with 542/27 nm emission and 504/12 nm excitation; IDA is the
intensity of fluorescence emission detected in the ‘‘FRET’’ channel
with 542/27 nm emission and 427/10 nm excitation; a and d are
cross-talk coefficients determined from acceptor-only or donor-
only samples, respectively. We determined the a value of 0.074 for
YFP and the d value of 0.7 for CFP. G is the ratio of the sensitized
emission to the corresponding amount of donor recovery, which
was 3.2 for this setup. The pixel-by-pixel FRET calculation
process was automated using a Visual Basic for Applications
macro in Excel.
Fluorescence correlation spectroscopy and photon
counting histogram analyses
For independent or uncorrelated processes, the contributions to
the fluctuation of fluorescence signals of a given molecule in FCS
studies are additive in nature [45]. A theoretical model for
analyzing the FCS curves for our YFP labeled proteins includes
the contribution from translational diffusion and the contributions
from the on-off dynamics of YFP caused by single/triplet and
protonated/unprotonated bright and dark states [46]. Such a
model for a single species undergoing diffusion in a 3-dimensional
Gaussian excitation volume is given by
g t ðÞ ~1z
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the excitation volume defined by dimensions z and v. tD is the
translation diffusion time of the protein and Pi and tPi define the
on-off dynamics of YFP. For the case of a mixture of molecules
with different translation diffusion times, the equation 1 was
modified as
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where Nj gives the average number of j
th species in the excitation
volume with a corresponding brightness of ej. The measured FCS
curves were fit to the corresponding theoretical model using a
nonlinear fitting routine minimizing x
2 and the correctness of the
fits was judged by evaluating the residuals.
The diffusion coefficients were calculated from the measured tD
values according to D~v2 
4tD. The diffusion coefficient for YFP
was taken as a reference [47] for calculation of the diffusion
coefficient for dysferlin. Assuming a spherical shape for the
diffusing particle, the hydrodynamic radius was calculated for
dysferlin using
rh~kT=6pgD, ð3Þ
where k is the Boltzmann constant (1.38610
223 J/K), T the
temperature and g the viscosity of the medium.
The PCH were analyzed using a nonlinear fitting routine with
the molecular brightness (ej) and average number of molecules in
excitation volume (Nj) as variables. For a mixture of 2 independent
species of particles diffusing through the excitation volume, the
PCH function is a convolution between the PCH functions of the
individual species [37] yielding the average number of particles in
the excitation volume (N1 and N2) and the molecular brightness (e1
and e2) for the first and second species. The molecular brightness
and average particle number corresponding to the background
autofluorescence was determined from the detergent solutions. A
global analysis of multiple measurements was performed for a
more robust determination of the fitted parameters.
For FCS and PCH studies, the YFP labeled protein samples
were added into an 8-well glass chamber (Lab-Tek, Nunc) placed
on the stage of a confocal microscope (TCS-SP5, Leica
Microsystems). The samples were excited at 512 nm wavelength
with an Ar-ion continuous wave laser that was attenuated to
prevent photobleaching (the laser power was 4.5 mW at the
sample). Fluorescence emission was collected with a 636 water
immersion objective (HCX PL APO, 1.2 NA) and band pass filter
(535–585 nm). Detection was by an avalanche photodiode
(SPCM-AQRH, Perkin Elmer) and the time information of the
detected photons was recorded by a photon counting card (ISS
Inc.). FCS curves and PCH were generated by ISS-Vista software.
The PCH were analyzed using a time bin width of 20 ms, which
was much shorter than the translational diffusion time of the
molecule in solution. Fluorescence traces were integrated for
100 seconds for each measurement. A 1-photon 3-dimensional
Gaussian model was assumed for the excitation volume in our
experiments.
Statistical analysis
Data were presented as mean 6 SEM, and statistical
significance (p,0.05) was determined by the Student’s t-test or
one-way ANOVA using Prism 5.02 (Graphpad).
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